683 Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Buy |
1,080,000
+604,000
| +127% | +$2.31M | 0.27% | 68 |
|
|
2025
Q1 | $2.74M | Buy |
476,000
+186,000
| +64% | +$1.07M | 0.19% | 82 |
|
|
2024
Q4 | $1.45M | Buy |
+290,000
| New | +$1.45M | 0.09% | 86 |
|
|
2023
Q2 | – | Sell |
-19,000
| Closed | -$189K | – | 148 |
|
|
2023
Q1 | $189K | Sell |
19,000
-10,519
| -36% | -$104K | 0.01% | 139 |
|
|
2022
Q4 | $205K | Sell |
29,519
-670,481
| -96% | -$4.67M | 0.02% | 149 |
|
|
2022
Q3 | $3.74M | Sell |
700,000
-300,000
| -30% | -$1.6M | 0.29% | 75 |
|
|
2022
Q2 | $3.99M | Buy |
1,000,000
+500,000
| +100% | +$2M | 0.28% | 80 |
|
|
2022
Q1 | $2.22M | Buy |
+500,000
| New | +$2.22M | 0.12% | 108 |
|
|
2021
Q1 | – | Sell |
-216,818
| Closed | -$1.49M | – | 157 |
|
|
2020
Q4 | $1.49M | Buy |
216,818
+51,818
| +31% | +$355K | 0.07% | 97 |
|
|
2020
Q3 | $1.22M | Hold |
165,000
| – | – | 0.09% | 81 |
|
|
2020
Q2 | $688K | Sell |
165,000
-760,000
| -82% | -$3.17M | 0.06% | 89 |
|
|
2020
Q1 | $2.28M | Sell |
925,000
-802,700
| -46% | -$1.98M | 0.27% | 54 |
|
|
2019
Q4 | $10M | Sell |
1,727,700
-622,300
| -26% | -$3.62M | 1.15% | 17 |
|
|
2019
Q3 | $12.4M | Buy |
2,350,000
+224,219
| +11% | +$1.18M | 1.38% | 15 |
|
|
2019
Q2 | $12.8M | Buy |
2,125,781
+325,781
| +18% | +$1.95M | 1.16% | 18 |
|
|
2019
Q1 | $16.3M | Buy |
1,800,000
+406,300
| +29% | +$3.67M | 1.47% | 12 |
|
|
2018
Q4 | $11.6M | Buy |
1,393,700
+43,700
| +3% | +$363K | 0.7% | 16 |
|
|
2018
Q3 | $18.6M | Buy |
1,350,000
+350,000
| +35% | +$4.83M | 1.21% | 11 |
|
|
2018
Q2 | $7.95M | Hold |
1,000,000
| – | – | 0.54% | 26 |
|
|
2018
Q1 | $7.5M | Buy |
1,000,000
+85,000
| +9% | +$638K | 0.66% | 29 |
|
|
2017
Q4 | $6.22M | Buy |
915,000
+79,486
| +10% | +$541K | 0.52% | 32 |
|
|
2017
Q3 | $6.02M | Buy |
835,514
+310,421
| +59% | +$2.24M | 0.63% | 34 |
|
|
2017
Q2 | $2.44M | Buy |
+525,093
| New | +$2.44M | 0.36% | 47 |
|